Testing for viral DNA integration among HPV‐positive women to detect cervical precancer: An observational cohort study
BJOG: An International Journal of Obstetrics & Gynaecology · 2024-02 · 131 (3) · 309-318
DOI: 10.1111/1471-0528.17597 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 06.07.2023. Verfasst von Ting Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key research and development program, Wuhan Scientific and Technical Achievements Project.
Abstract (Originalsprache)
Objective
Human papillomavirus (HPV) integration is a crucial genetic step in cervical carcinogenesis. This study aimed to evaluate the performance of an HPV integration test for the triage of HPV‐positive women.
Design
An observational cohort study.
Setting
A cervical cancer screening programme in China. Population 1393 HPV‐positive women aged 25–65 years undergoing routine cervical cancer screening and HPV integration testing with 1‐year follow‐up.
Methods
The sensitivity, specificity, positive predictive value and negative predictive value between HPV integration and cytology were compared. Main outcome measures Cervical intraepithelial neoplasia grade 3 or more severe (CIN3+).
Results
Among 1393 HPV‐positive patients, 138 (9.9% [8.3–11.5%]) were HPV integration test positive compared with 537 who had abnormal cervical cytology (38.5% [36.0–41.1%]). Compared with cytology, HPV integration exhibited higher specificity (94.5% [93.3–95.8%] versus 63.8% [61.2–66.4%]) and equivalent sensitivity (70.5% [61.4–79.7%] versus 70.5% [61.4–79.7%]) for detection of CIN3+. HPV integration‐negative women accounted for 90.1% (1255/1393) of the total population and had a low immediate CIN3+ risk (2.2%). At 1‐year follow‐up, the progression rate in the HPV integration‐positive women was higher than in the HPV integration‐negative women (12.0% versus 2.1%, odds ratio 5.6, 95% CI, 2.6–11.9). In 10 conservatively managed integration‐negative CIN2 patients, all showed spontaneous regression and seven showed HPV clearance after 1‐year follow‐up.
Conclusion
The HPV integration test may be a precise risk stratification tool for HPV‐positive women and could avoid excessive use of invasive biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecological Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- National Clinical Research Centre for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and…
- Wuhan KDWS Biological Technology Co., Ltd, New Technology Platform, Wuhan, China.
- Department of Gynaecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
- Department of Gynaecology and Obstetrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Hui Wang
Förderung
- National Natural Science Foundation of China
- National Key research and development program
- Wuhan Scientific and Technical Achievements Project
- National Key Research and Development Program of China
Zitieren
APA
Hu, T., Li, K., He, L., Huang, F., Yang, F., Chen, S., Wang, H., Ma, D., Huang, X., & Wu, P. (2024). Testing for viral DNA integration among HPV‐positive women to detect cervical precancer: An observational cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 131(3), 309-318. https://doi.org/10.1111/1471-0528.17597
Vancouver
Hu T, Li K, He L, Huang F, Yang F, Chen S, et al. Testing for viral DNA integration among HPV‐positive women to detect cervical precancer: An observational cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2024;131(3):309-318. doi:10.1111/1471-0528.17597
BibTeX
@article{Hu2024,
author = {Hu, Ting and Li, Kexin and He, Liang and Huang, Fanwei and Yang, Fan and Chen, Shimin and Wang, Hui and Ma, Ding and Huang, Xiaoyuan and Wu, Peng},
title = {Testing for viral DNA integration among HPV‐positive women to detect cervical precancer: An observational cohort study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
volume = {131},
number = {3},
pages = {309--318},
doi = {10.1111/1471-0528.17597}
}
EUVIMED